Who invested in Tarveda Therapeutics?
Tarveda Therapeutics's investors include Flagship Pioneering, New Enterprise Associates, Versant Ventures, Novo Holdings and Nano Dimension, and 2 more on record.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$36Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $6.0M sold, first sale Sept 2021
Reported by FinSMEsSEC filing: $38M sold, first sale Jan 2016
From the SEC filings it signed: 1 on the team.
On the board, as filediAymeric SallinDennis AusielloGuido MagniMichael MetzgerNilesh Kumar
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tarveda Therapeutics's investors include Flagship Pioneering, New Enterprise Associates, Versant Ventures, Novo Holdings and Nano Dimension, and 2 more on record.
Tarveda Therapeutics has raised $36M across 2 rounds since 2017.
Tarveda Therapeutics's most recent round was a Venture of $6.0M in Sept 2021.
Tarveda Therapeutics's largest round on record is $30M (Series D), in Feb 2017.
Tarveda Therapeutics's first round on record, in Feb 2017, was backed by Flagship Pioneering, Nano Dimension and Novo A/S and 1 others.
Tarveda Therapeutics's latest named round is a Venture, in Sept 2021.
Tarveda Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.